chronic myeloid leukaemia patient Latest Research Papers

Extramedullary blast crisis in a chronic myeloid leukaemia patient after achieving a major molecular response with bosutinib

British Journal of Haematology ◽

10.1111/bjh.17771 ◽

2021 ◽

Author(s):

Rui Nakajima ◽

Takuji Matsuo ◽

Ritsu Sumiyoshi ◽

Sumiko Saito ◽

Tadashi Yamamoto ◽

...

Keyword(s):

Chronic Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Blast Crisis ◽

Molecular Response ◽

Chronic Myeloid Leukaemia Patient ◽

Major Molecular Response ◽

Extramedullary Blast Crisis ◽

Leukaemia Patient

Breakpoint mapping of a t(9;22;12) chronic myeloid leukaemia patient with e14a3 BCR‐ABL1 transcript using Nanopore sequencing

The Journal of Gene Medicine ◽

10.1002/jgm.3276 ◽

2020 ◽

Author(s):

Hu Zhao ◽

Yuan Chen ◽

Chanjuan Shen ◽

Lingshu Li ◽

Qingzhao Li ◽

...

Keyword(s):

Chronic Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Nanopore Sequencing ◽

Chronic Myeloid Leukaemia Patient ◽

Breakpoint Mapping ◽

Leukaemia Patient

Evaluation of the plasma concentration of ponatinib in a chronic myeloid leukaemia patient with ponatinib intolerance

Journal of Clinical Pharmacy and Therapeutics ◽

10.1111/jcpt.13257 ◽

2020 ◽

Vol 46 (1) ◽

pp. 219-222

Author(s):

Maiko Abumiya ◽

Naoto Takahashi ◽

Tomoko Yoshioka ◽

Yoshihiro Kameoka ◽

Masatomo Miura

Keyword(s):

Plasma Concentration ◽

Chronic Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Chronic Myeloid Leukaemia Patient ◽

Leukaemia Patient

PB1922 PONATINIB INDUCES A SUSTAINED DEEP MOLECULAR RESPONSE IN A CHRONIC MYELOID LEUKAEMIA PATIENT WITH AN EARLY RELAPSE WITH A T315I MUTATION FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

HemaSphere ◽

10.1097/01.hs9.0000566188.04988.71 ◽

2019 ◽

Vol 3 (S1) ◽

pp. 874

Author(s):

N. Cerveira ◽

R.B. Ferreira ◽

S. Bizarro ◽

C. Correira ◽

L. Torres ◽

...

Keyword(s):

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Chronic Myeloid Leukaemia ◽

Molecular Response ◽

Chronic Myeloid Leukaemia Patient ◽

Hematopoietic Stem ◽

Early Relapse ◽

Deep Molecular Response ◽

T315i Mutation ◽

Leukaemia Patient

Ponatinib induces a sustained deep molecular response in a chronic myeloid leukaemia patient with an early relapse with a T315I mutation following allogeneic hematopoietic stem cell transplantation: a case report

BMC Cancer ◽

10.1186/s12885-018-5100-4 ◽

2018 ◽

Vol 18 (1) ◽

Cited By ~ 5

Author(s):

Nuno Cerveira ◽

Rosa Branca Ferreira ◽

Susana Bizarro ◽

Cecília Correia ◽

Lurdes Torres ◽

...

Keyword(s):

Stem Cell ◽

Case Report ◽

Hematopoietic Stem Cell Transplantation ◽

Molecular Response ◽

Chronic Myeloid Leukaemia Patient ◽

Hematopoietic Stem ◽

Early Relapse ◽

Deep Molecular Response ◽

T315i Mutation ◽

Leukaemia Patient

Gastrointestinal bleeding in a chronic myeloid leukaemia patient precipitated by dasatinib-induced platelet dysfunction: Case report

Platelets ◽

10.3109/09537104.2015.1049138 ◽

2015 ◽

Vol 26 (8) ◽

pp. 809-811 ◽

Cited By ~ 17

Author(s):

Louise Kostos ◽

Kate Burbury ◽

Gaurav Srivastava ◽

H. Miles Prince

Keyword(s):

Case Report ◽

Chronic Myeloid Leukaemia ◽

Gastrointestinal Bleeding ◽

Myeloid Leukaemia ◽

Chronic Myeloid Leukaemia Patient ◽

Platelet Dysfunction ◽

Leukaemia Patient

Undetectable molecular residual disease after omacetaxine and nilotinib combination therapy in an imatinib-resistant chronic myeloid leukaemia patient harbouring the BCR-ABL1 T315I gatekeeper mutation

British Journal of Haematology ◽

10.1111/j.1365-2141.2011.09016.x ◽

2012 ◽

Vol 157 (3) ◽

pp. 407-410 ◽

Cited By ~ 12

Author(s):

Marie-Magdelaine Coude ◽

Odile Luycx ◽

Marie-Estelle Cariou ◽

Odile Maarek ◽

Hervé Dombret ◽

...

Keyword(s):

Combination Therapy ◽

Chronic Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Residual Disease ◽

Chronic Myeloid Leukaemia Patient ◽

Imatinib Resistant ◽

Leukaemia Patient

Recurrent imatinib-induced hepatotoxicity in a chronic myeloid leukaemia patient successfully managed with prednisone

BMJ Case Reports ◽

10.1136/bcr.11.2010.3516 ◽

2011 ◽

Vol 2011 (feb21 2) ◽

pp. bcr1120103516-bcr1120103516 ◽

Cited By ~ 2

Author(s):

S. Gupta ◽

V. R. Bhatt ◽

S. Varma

Keyword(s):

Chronic Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Chronic Myeloid Leukaemia Patient ◽

Leukaemia Patient

Sequential development of mutant clones in an imatinib resistant chronic myeloid leukaemia patient following sequential treatment with multiple tyrosine kinase inhibitors: an emerging problem?

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-008-0905-5 ◽

2009 ◽

Vol 64 (1) ◽

pp. 195-197 ◽

Cited By ~ 3

Author(s):

Massimo Breccia ◽

Anna Maria Frustaci ◽

Laura Cannella ◽

Simona Soverini ◽

Caterina Stefanizzi ◽

...

Keyword(s):

Chronic Myeloid Leukaemia ◽

Tyrosine Kinase ◽

Myeloid Leukaemia ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Sequential Treatment ◽

Chronic Myeloid Leukaemia Patient ◽

Sequential Development ◽

Imatinib Resistant ◽

Leukaemia Patient

Restoration of donor chimerism by nilotinib in a chronic myeloid leukaemia patient post mutation-associated imatinib mesylate resistance and allogeneic stem cell transplant failure

Bone Marrow Transplantation ◽

10.1038/bmt.2008.250 ◽

2008 ◽

Vol 42 (12) ◽

pp. 833-835 ◽

Cited By ~ 3

Author(s):

L M O'Connor ◽

S Langabeer ◽

S R McCann ◽

E Conneally

Keyword(s):

Stem Cell ◽

Chronic Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Imatinib Mesylate ◽

Stem Cell Transplant ◽

Cell Transplant ◽

Chronic Myeloid Leukaemia Patient ◽

Allogeneic Stem Cell Transplant ◽

Transplant Failure ◽

Leukaemia Patient

chronic myeloid leukaemia patient
Recently Published Documents

TOTAL DOCUMENTS

H-INDEX

Extramedullary blast crisis in a chronic myeloid leukaemia patient after achieving a major molecular response with bosutinib

Breakpoint mapping of a t(9;22;12) chronic myeloid leukaemia patient with e14a3 BCR‐ABL1 transcript using Nanopore sequencing

Evaluation of the plasma concentration of ponatinib in a chronic myeloid leukaemia patient with ponatinib intolerance

PB1922 PONATINIB INDUCES A SUSTAINED DEEP MOLECULAR RESPONSE IN A CHRONIC MYELOID LEUKAEMIA PATIENT WITH AN EARLY RELAPSE WITH A T315I MUTATION FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

Ponatinib induces a sustained deep molecular response in a chronic myeloid leukaemia patient with an early relapse with a T315I mutation following allogeneic hematopoietic stem cell transplantation: a case report

Gastrointestinal bleeding in a chronic myeloid leukaemia patient precipitated by dasatinib-induced platelet dysfunction: Case report

Undetectable molecular residual disease after omacetaxine and nilotinib combination therapy in an imatinib-resistant chronic myeloid leukaemia patient harbouring the BCR-ABL1 T315I gatekeeper mutation

Recurrent imatinib-induced hepatotoxicity in a chronic myeloid leukaemia patient successfully managed with prednisone

Sequential development of mutant clones in an imatinib resistant chronic myeloid leukaemia patient following sequential treatment with multiple tyrosine kinase inhibitors: an emerging problem?

Restoration of donor chimerism by nilotinib in a chronic myeloid leukaemia patient post mutation-associated imatinib mesylate resistance and allogeneic stem cell transplant failure

Export Citation Format

chronic myeloid leukaemia patientRecently Published Documents

TOTAL DOCUMENTS

H-INDEX

Extramedullary blast crisis in a chronic myeloid leukaemia patient after achieving a major molecular response with bosutinib

Breakpoint mapping of a t(9;22;12) chronic myeloid leukaemia patient with e14a3 BCR‐ABL1 transcript using Nanopore sequencing

Evaluation of the plasma concentration of ponatinib in a chronic myeloid leukaemia patient with ponatinib intolerance

PB1922 PONATINIB INDUCES A SUSTAINED DEEP MOLECULAR RESPONSE IN A CHRONIC MYELOID LEUKAEMIA PATIENT WITH AN EARLY RELAPSE WITH A T315I MUTATION FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

Ponatinib induces a sustained deep molecular response in a chronic myeloid leukaemia patient with an early relapse with a T315I mutation following allogeneic hematopoietic stem cell transplantation: a case report

Gastrointestinal bleeding in a chronic myeloid leukaemia patient precipitated by dasatinib-induced platelet dysfunction: Case report

Undetectable molecular residual disease after omacetaxine and nilotinib combination therapy in an imatinib-resistant chronic myeloid leukaemia patient harbouring the BCR-ABL1 T315I gatekeeper mutation

Recurrent imatinib-induced hepatotoxicity in a chronic myeloid leukaemia patient successfully managed with prednisone

Sequential development of mutant clones in an imatinib resistant chronic myeloid leukaemia patient following sequential treatment with multiple tyrosine kinase inhibitors: an emerging problem?

Restoration of donor chimerism by nilotinib in a chronic myeloid leukaemia patient post mutation-associated imatinib mesylate resistance and allogeneic stem cell transplant failure

chronic myeloid leukaemia patient
Recently Published Documents